FourThought Financial’s West Pharmaceutical WST Stock Holding History

FourThought Financial’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$28K	Buy	114 +33	+41%	+$10.1K	﹤0.01%	780
2022 Q2	$24K	Hold	81	–	–	﹤0.01%	825
2022 Q1	$33K	Hold	81	–	–	﹤0.01%	787
2021 Q4	$38K	Sell	81 -33	-29%	-$14.2K	﹤0.01%	756
2021 Q3	$48K	Hold	114	–	–	0.01%	705
2021 Q2	$40K	Hold	114	–	–	0.01%	774
2021 Q1	$32K	Hold	114	–	–	﹤0.01%	800
2020 Q4	$32K	Buy	+114	New	+$32K	0.01%	774

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FourThought Financial's WST Position: Q3 2022 in Review

FourThought Financial increased its West Pharmaceutical (WST) stake by 41% in Q3 2022, buying an estimated $10.1K and bringing the position to 114 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #780.

FourThought Financial first reported a position in WST in Q4 2020 and has held it in 8 quarters since. The position peaked at $48K in Q3 2021. 639 funds tracked by Wall St. Rank hold WST as of Q3 2022.

FourThought Financial held 114 shares of West Pharmaceutical worth $28K as of Q3 2022.
FourThought Financial bought 33 West Pharmaceutical shares in Q3 2022, an estimated $10.1K.
West Pharmaceutical made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #780 holding.
FourThought Financial first reported a position in West Pharmaceutical in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's West Pharmaceutical position peaked at $48K in Q3 2021.
639 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.